330 related articles for article (PubMed ID: 34006679)
21. Myelin oligodendrocyte glycoprotein antibody associated central nervous system demyelinating disease: a tertiary center experience from Turkey.
Inan B; Gocmen R; Vural A; Colpak AI; Meinl E; Karabudak R; Tuncer A
Mult Scler Relat Disord; 2020 Sep; 44():102376. PubMed ID: 32674059
[TBL] [Abstract][Full Text] [Related]
22. Atypical MOG antibody disease presenting with typical multiple sclerosis lesions.
Dolbec K; Chalkley J; Sudhakar P
Mult Scler Relat Disord; 2020 Sep; 44():102342. PubMed ID: 32615531
[TBL] [Abstract][Full Text] [Related]
23. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
[TBL] [Abstract][Full Text] [Related]
24. Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody.
Ikeda K; Kiyota N; Kuroda H; Sato DK; Nishiyama S; Takahashi T; Misu T; Nakashima I; Fujihara K; Aoki M
Mult Scler; 2015 Apr; 21(5):656-9. PubMed ID: 25257613
[TBL] [Abstract][Full Text] [Related]
25. Aseptic Meningitis as an Initial Manifestation of Anti-myelin Oligodendrocyte Glycoprotein Antibody-associated Disease.
Suzuki T; Maekawa K; Matsuo K; Yamasaki M; Shibata M; Takahashi T; Naito Y
Intern Med; 2019 Nov; 58(22):3319-3321. PubMed ID: 31327827
[TBL] [Abstract][Full Text] [Related]
26. Clinical risk factors for recurrence of myelin oligodendrocyte glycoprotein antibody-associated disease.
Wang J; Yang K; Zhang F; Yi Y; Wang J
Mult Scler Relat Disord; 2023 Sep; 77():104879. PubMed ID: 37442076
[TBL] [Abstract][Full Text] [Related]
27. Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration.
Havla J; Kümpfel T; Schinner R; Spadaro M; Schuh E; Meinl E; Hohlfeld R; Outteryck O
J Neurol; 2017 Jan; 264(1):139-151. PubMed ID: 27844165
[TBL] [Abstract][Full Text] [Related]
28. MOG antibody disease: A review of MOG antibody seropositive neuromyelitis optica spectrum disorder.
Narayan R; Simpson A; Fritsche K; Salama S; Pardo S; Mealy M; Paul F; Levy M
Mult Scler Relat Disord; 2018 Oct; 25():66-72. PubMed ID: 30048919
[TBL] [Abstract][Full Text] [Related]
29. The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients.
Siritho S; Sato DK; Kaneko K; Fujihara K; Prayoonwiwat N
Mult Scler; 2016 Jun; 22(7):964-8. PubMed ID: 26498263
[TBL] [Abstract][Full Text] [Related]
30. Postinfectious Anti-Myelin Oligodendrocyte Glycoprotein Antibody Positive Optic Neuritis and Myelitis.
Vieira JP; Sequeira J; Brito MJ
J Child Neurol; 2017 Oct; 32(12):996-999. PubMed ID: 28820014
[TBL] [Abstract][Full Text] [Related]
31. Serial Anti-Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes.
Waters P; Fadda G; Woodhall M; O'Mahony J; Brown RA; Castro DA; Longoni G; Irani SR; Sun B; Yeh EA; Marrie RA; Arnold DL; Banwell B; Bar-Or A;
JAMA Neurol; 2020 Jan; 77(1):82-93. PubMed ID: 31545352
[TBL] [Abstract][Full Text] [Related]
32. [Anti-MOG Antibody Associated Diseases].
Nakashima I
Brain Nerve; 2017 Nov; 69(11):1331-1336. PubMed ID: 29172198
[TBL] [Abstract][Full Text] [Related]
33. Persistent MOG-IgG positivity is a predictor of recurrence in MOG-IgG-associated optic neuritis, encephalitis and myelitis.
Oliveira LM; Apóstolos-Pereira SL; Pitombeira MS; Bruel Torretta PH; Callegaro D; Sato DK
Mult Scler; 2019 Dec; 25(14):1907-1914. PubMed ID: 30417715
[TBL] [Abstract][Full Text] [Related]
34. CNS inflammatory demyelinating disorders: MS, NMOSD and MOG antibody associated disease.
Rosenthal JF; Hoffman BM; Tyor WR
J Investig Med; 2020 Feb; 68(2):321-330. PubMed ID: 31582425
[TBL] [Abstract][Full Text] [Related]
35. Clinical and neuroimaging characteristics of MOG autoimmunity in children with acquired demyelinating syndromes.
Ferilli MAN; Valeriani M; Papi C; Papetti L; Ruscitto C; Figà Talamanca L; Ursitti F; Moavero R; Vigevano F; Iorio R
Mult Scler Relat Disord; 2021 May; 50():102837. PubMed ID: 33636614
[TBL] [Abstract][Full Text] [Related]
36. A rare concurrence: Antibodies against Myelin Oligodendrocyte Glycoprotein and N-methyl-d-aspartate receptor in a child.
Sarigecili E; Cobanogullari MD; Komur M; Okuyaz C
Mult Scler Relat Disord; 2019 Feb; 28():101-103. PubMed ID: 30590238
[TBL] [Abstract][Full Text] [Related]
37. [Optic neuropathy in positive anti-MOG antibody syndrome].
Merabtene L; Vignal Clermont C; Deschamps R
J Fr Ophtalmol; 2019 Dec; 42(10):1100-1110. PubMed ID: 31732265
[TBL] [Abstract][Full Text] [Related]
38. Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations.
Juryńczyk M; Jacob A; Fujihara K; Palace J
Pract Neurol; 2019 Jun; 19(3):187-195. PubMed ID: 30530724
[TBL] [Abstract][Full Text] [Related]
39. Myelin oligodendrocyte glycoprotein antibodies in neuromyelitis optica spectrum disorder.
de Seze J
Curr Opin Neurol; 2019 Feb; 32(1):111-114. PubMed ID: 30562266
[TBL] [Abstract][Full Text] [Related]
40. Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies.
Lee HJ; Kim B; Waters P; Woodhall M; Irani S; Ahn S; Kim SJ; Kim SM
J Neuroinflammation; 2018 Oct; 15(1):302. PubMed ID: 30382857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
